Transmissible spongiform encephalopathy in goats: is PrP rapid test sensitivity affected by genotype?

Abstract

Transmissible spongiform encephalopathy (TSE) surveillance in goats relies on tests initially approved for cattle, subsequently assessed for sheep, and approval extrapolated for use in "small ruminants." The current EU-approved immunodetection tests employ antibodies against various epitopes of the prion protein PrP, which is encoded by the hostgene. The caprinegene is polymorphic, mostly at codons different from the ovine. The EU goat population is much more heterogeneous than the sheep population, with more-related polymorphisms, and with marked breed-related differences. The ability of the current tests to detect disease-specific PrPgenerated against these different genetic backgrounds is currently assumed, rather than proven. We examined whether common polymorphisms within the goatgene might have any adverse effect on the relative performance of EU-approved rapid tests. The sample panel comprised goats from the UK, Cyprus, France, and Italy, with either experimental or naturally acquired scrapie at both the preclinical and/or unknown and clinical stages of disease. Test sensitivity was significantly lower and more variable when compared using samples from animals that were preclinical or of unknown status. However, all of the rapid tests included in our study were able to correctly identify all samples from animals in the clinical stages of disease, apart from samples from animals polymorphic for serine or aspartic acid at codon 146, in which the performance of the Bio-Rad tests was profoundly affected. Our data show that some polymorphisms may adversely affect one test and not another, as well as underline the dangers of extrapolating from other species.